• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
December 23 - According to the Sing Tao Daily, Biren Technology began accepting subscriptions for its Hong Kong initial public offering (IPO) on Monday, with margin financing oversubscribed by nearly 47 times on the first day. The company plans to issue 247.7 million shares, aiming to raise up to HK$4.85 billion.On December 23, the U.S. Food and Drug Administration (FDA) approved the oral tablet version of Novo Nordisks weight-loss drug Wegovy. Novo Nordisk refers to the drug as Wegovy oral tablets. Its active ingredient is the same as the original Wegovy and its diabetes sister drug Ozempic, both being semaglutide. Wegovy and Ozempic are both weekly injectable GLP-1 hormone mimics, as are their competitors Eli Lillys Zepbound and Mounjaro. According to the Kaiser Family Foundation, a health policy research organization, approximately one in eight adults in the U.S. are currently taking one of these medications. Novo Nordisk stated that clinical trials showed that the weight-loss effects and side effects of Wegovy oral tablets are broadly similar to those of the Wegovy injection, and it will be available in the U.S. with a prescription starting in January. Novo Nordisks Chief Medical Officer for the U.S., Brett, stated, "We believe this will expand patient choice and accessibility; we know some patients simply do not want to use injectable medications."December 23 – Since the Trump administration tightened restrictions on Venezuelan oil revenues by locking down tankers, more than a dozen oil tankers have been loading oil off the Venezuelan coast. According to shipping intelligence firm Kepler, approximately 14 vessels have completed loading since December 11, at least six of which are sanctioned. Most loading operations have taken place in the ports of Bajo Grande and Jose. Data shows that despite escalating tensions, oil loading activity is proceeding at a near-normal pace.Novo Nordisk (NVO.N): Novo Nordisks Wegovy is being manufactured in the United States.US President Trump: Everyone is tired of Russias war in Ukraine.

S&P 500 Price Forecast – Stock Markets Continue to Worry About Rates

Jimmy Khan

Feb 22, 2023 16:31


Technical Analysis of the S&P 500

The S&P 500 E-mini contract started overnight trading poorly and hasn't been making a lot of sense. Yet, the contract's high level of volatility persists, and as a result, downward pressure is beginning to build. It's important to note that the 200-Day EMA and the 50-Day EMA are located immediately below. Given that they are both rather flat, there may not actually be any momentum.


As it is slightly above the psychologically and structurally significant 4000 level, this may pave the way for a support level to develop in that approximate area. You must keep in mind that earnings season is now underway because it could cause the market to fluctuate. The moving averages and the psychologically significant 4000 level, if we were to break down below them, might drive the futures market and the index itself significantly lower.


It thus creates the chance of a decline down to the 3900 level, where we had experienced some buying pressure. Following that, there comes the 3800 level, which is considerably more significant and will get a lot of attention. When it comes to whether or not the market can save itself, we would be in that general area hanging on by a thread.


The previous two candlesticks have undoubtedly looked pretty bearish, and I think that may have some momentum built up in it. If the market were to flip around and bounce, then it may try to move towards the 4200 level. The minutes from the Federal Open Market Committee meeting, which are released on Wednesday, will undoubtedly also be relevant. This ought to provide traders a good indication of what the Federal Reserve members discussed during the meeting and whether or not there is an overall hawkish mindset or if there are any ice cracks appearing. This will have a significant impact on the market.